Speaker: Hanlee Ji, M.D., Medical Oncologist, Hematologist / Oncologist in Stanford University
Cancer’s complexity is evident by its sheer breadth of somatic genetic errors that occur during tumor development and progression. Successfully implementing cancer precision medicine will require systematically deconvoluting these cancer genetic aberrations to extract clinically relevant information; this will require understanding these genetic errors in the context of spatial, temporal and clonal admixture changes. Highly sensitive, specific and innovative technological and computational approaches will be required for measuring multi-dimensional genetic states from cancer patients. This will involve the analysis of cancer as it clinically progresses. The results of such studies will have enormous impact on the future of cancer medicine and our patients.